Skip to main content
. 2011 Nov;72(5):758–767. doi: 10.1111/j.1365-2125.2011.04005.x

Table 3.

Population pharmacokinetic parameters of ceftriaxone

Estimation Bootstrap
Parameter Final estimate SE of the estimate 95% CI* Median 95% CI
PK
CL (l h−1) = θ12× (CLcr/4.26)
θ1 0.56 0.11 0.34 0.78 0.56 0.37 0.85
θ2 0.32 0.12 0.08 0.56 0.32 0.005 0.56
V1 (l) 10.3 0.89 8.56 12.04 10.0 6.24 13.4
V2 (l) 7.35 0.75 5.88 8.82 7.48 4.81 10.9
Q (l h−1) 5.28 1.37 2.59 7.97 5.12 1.16 14.4
BSV ω2 (% coefficient variation)
ω2 (CL) 0.24 (49) 0.05 0.14 0.34 0.25 0.15 0.38
ω2 (V1) 0.23 (48) 0.06 0.11 0.35 0.24 0.11 0.43
ω2 (V2) 0.42 (65) 0.11 0.20 0.64 0.38 0.18 1.76
Residual variability σ2
σ2 proportional (%) 24 0.009 21 28 24 21 28
*

(mean estimate ± 1.96 SE of the estimates) for θ; (mean estimate ± 1.96 SE of the estimates)1/2 for ω and σ.

The 2.5th and 97.5th percentiles of 500 bootstrap distribution of parameter estimates. V1, volume of the central compartment; V2, volume of the peripheral compartment; CL, clearance of ceftriaxone; CLcr, clearance of creatinine; Q, intercompartmental clearance.